Abstract
Patau syndrome, also known as trisomy 13 syndrome, is a syndrome caused by a chromosomal abnormality. This rare syndrome is a lethal disease, where the life expectancy more than 1 year after birth is only less than 15%. The cause of Patau Syndrome is an abnormality on chromosome 13, where the possibilities that can occur are complete trisomy 13, translocation trisomy 13, partial trisomy 13 and mosaic trisomy 13. In addition to genetic factors, it was revealed that epigenetic factors have also played an important role in this syndrome, after it was discovered that DNA methylation occurring in a number of CpGs could be used as a potential biomarker to detect trisomy 13. The aim of this paper is to discuss the genetic and epigenetic factors involved in Patau Syndrome.
Original language | English |
---|---|
Title of host publication | Proceedings of the 4th International Conference on Life Sciences and Biotechnology (ICOLIB 2021) |
Editors | Asmoro Lelono, Muhammad Akbar Bahar, Syubanul Wathon, Kartika Senjarini, Asep Ginanjar Arip, Ramdhan Putrasetya, Beny Andika, Nadhea Ayu Sukma |
Publisher | Atlantis Press International B.V |
Chapter | 32 |
Pages | 321-329 |
ISBN (Electronic) | 978-94-6463-062-6 |
ISBN (Print) | 978-94-6463-061-9 |
DOIs | |
Publication status | Published - 22 Dec 2022 |
Keywords
- Patau syndrome
- Genetic
- Epigenetic
- DNA Methylation